Stapled lipopeptides show promise as broad-spectrum antivira

Compounds that obstruct the "landing gear" of a range of harmful viruses can successfully protect against infection by the virus that causes COVID-19, a study published today and led by Dana-Farber Cancer Institute scientists shows.

Related Keywords

Dana Farber Cancer Institute , Massachusetts , United States , Cambridge , Cambridgeshire , United Kingdom , Boston University , Richard Bowen , Aaron Moss , Loren Walensky , Robert Davey , Massachusetts Consortium On Pathogen Readiness , Microbiology At Boston University , Boston University National Emerging Infectious Diseases Laboratories , Colorado State University , National Institutes Of Health , Blood Disorders Center , Nature Communications , Farber Cancer , Principal Investigator , Linde Program , Cancer Chemical Biology , Boston Children , Blood Disorders , Gregory Bird , Red Queen Therapeutics , Queen Therapeutics , Red Queen , Massachusetts Consortium , Pathogen Readiness , National Institutes , Pre Clinical Services Program , National Institute , Infectious Diseases , Colorado State , Compound , Covid 19 , Virus , Antibodies , Flood , Dancer , Fell , Children , Clinical Trial , Coronavirus , Drugs , Revolution , Felix , Lungs , Embrane , Olecule , Nasal Spray , Pandemic , Eptides , Prophylaxis , Research , Espiratory , Cars , Ars Cov 2 , Technology , Herapeutics ,